R&D COVID-19: Celltrion's therapeutic option In just over a year, Celltrion Healthcare says it has identified and delivered a potential treatment for COVID-19.
News Joint MHRA/NICE pathway 'benefits industry over patients' LSE pharma policy expert contends the MHRA/NICE aligned pathway is weighted towards industry, and calls for an assessment of its impact on the NHS.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
